Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATAI Life Sciences B.V.*

1.42
-0.0500-3.40%
Volume:617.99K
Turnover:885.59K
Market Cap:281.60M
PE:-1.52
High:1.48
Open:1.45
Low:1.41
Close:1.47
Loading ...

Atai Life Sciences initiated with a Positive at Berenberg

TIPRANKS
·
04 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

ATAI Life Sciences Diversifies Treasury with Bitcoin Investment

TIPRANKS
·
20 Mar

ATAI Life Sciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Mar

Atai Life Sciences Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
19 Mar

TD Cowen Keeps Their Buy Rating on ATAI Life Sciences (ATAI)

TIPRANKS
·
18 Mar

ATAI Life Sciences Q4 EPS $(0.24) Misses $(0.15) Estimate

Benzinga
·
17 Mar

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire
·
17 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

GlobeNewswire
·
11 Mar

Atai Life Sciences completes enrollment of Phase 2b trial of BPL-003

TIPRANKS
·
05 Mar

atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression

GlobeNewswire
·
05 Mar

Atai Life Sciences N.V. (ATAI): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
02 Mar

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
25 Feb

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

GlobeNewswire
·
20 Feb

ATAI Life Sciences Announces Public Offering Pricing

TIPRANKS
·
14 Feb

ATAI Life Sciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Feb

Atai Life Sciences Prices $55 Million Stock Offering

MT Newswires Live
·
13 Feb

atai Life Sciences Says Pricing Of Registered Underwritten Offering Of 26.1 Million Common Shares At $2.10 Per Share

Reuters
·
13 Feb